$FTEK
FUEL TECH, INC.

2023 Q3 Form 10-Q Financial Statement

#000143774923022534 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $7.988M $5.461M
YoY Change -0.36% -14.24%
Cost Of Revenue $4.376M $3.465M
YoY Change 0.71% -6.1%
Gross Profit $3.612M $1.996M
YoY Change -1.63% -25.47%
Gross Profit Margin 45.22% 36.55%
Selling, General & Admin $2.966M $2.915M
YoY Change -9.38% 1.43%
% of Gross Profit 82.12% 146.04%
Research & Development $513.0K $413.0K
YoY Change 147.83% 42.91%
% of Gross Profit 14.2% 20.69%
Depreciation & Amortization $120.0K $94.00K
YoY Change 14.29% -24.19%
% of Gross Profit 3.32% 4.71%
Operating Expenses $3.479M $3.328M
YoY Change -0.03% 5.22%
Operating Profit $133.0K -$1.332M
YoY Change -30.73% 174.64%
Interest Expense $5.000K $5.000K
YoY Change 25.0% 25.0%
% of Operating Profit 3.76%
Other Income/Expense, Net $9.000K -$14.00K
YoY Change -73.53% -110.45%
Pretax Income $459.0K -$1.044M
YoY Change 46.18% 200.86%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $459.0K -$1.044M
YoY Change 46.18% 193.26%
Net Earnings / Revenue 5.75% -19.12%
Basic Earnings Per Share $0.02 -$0.03
Diluted Earnings Per Share $0.01 -$0.03
COMMON SHARES
Basic Shares Outstanding 30.39M 30.30M
Diluted Shares Outstanding 30.63M 30.32M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.30M $27.99M
YoY Change 6.59% -10.6%
Cash & Equivalents $13.48M $15.13M
Short-Term Investments $14.80M $12.86M
Other Short-Term Assets $1.000M $1.287M
YoY Change 43.68% -54.78%
Inventory $325.0K $528.0K
Prepaid Expenses
Receivables $7.696M $6.781M
Other Receivables $0.00 $0.00
Total Short-Term Assets $37.35M $36.59M
YoY Change 8.9% -10.73%
LONG-TERM ASSETS
Property, Plant & Equipment $4.364M $4.368M
YoY Change -3.13% -4.13%
Goodwill $2.116M $2.116M
YoY Change 0.0% 0.0%
Intangibles $376.0K $382.0K
YoY Change -8.29% -8.17%
Long-Term Investments $4.900M $4.874M
YoY Change -33.23%
Other Assets $771.0K $789.0K
YoY Change -2.53% -2.71%
Total Long-Term Assets $12.97M $13.02M
YoY Change -15.69% 60.1%
TOTAL ASSETS
Total Short-Term Assets $37.35M $36.59M
Total Long-Term Assets $12.97M $13.02M
Total Assets $50.32M $49.61M
YoY Change 1.28% 1.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.872M $3.097M
YoY Change 9.37% 31.9%
Accrued Expenses $1.200M $1.091M
YoY Change -23.76% -1.18%
Deferred Revenue $1.365M $938.0K
YoY Change 684.48% 62.28%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.431M $5.126M
YoY Change 24.17% 27.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $275.0K $280.0K
YoY Change 13.17% 9.8%
Total Long-Term Liabilities $275.0K $280.0K
YoY Change 13.17% 9.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.431M $5.126M
Total Long-Term Liabilities $275.0K $280.0K
Total Liabilities $6.231M $5.959M
YoY Change 28.47% 31.4%
SHAREHOLDERS EQUITY
Retained Earnings -$117.0M -$117.4M
YoY Change 1.21% 1.33%
Common Stock $165.1M $165.0M
YoY Change 0.25% 0.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.09M $43.65M
YoY Change
Total Liabilities & Shareholders Equity $50.32M $49.61M
YoY Change 1.28% 1.0%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $459.0K -$1.044M
YoY Change 46.18% 193.26%
Depreciation, Depletion And Amortization $120.0K $94.00K
YoY Change 14.29% -24.19%
Cash From Operating Activities $370.0K -$993.0K
YoY Change -49.32% -36.95%
INVESTING ACTIVITIES
Capital Expenditures $100.0K $73.00K
YoY Change -308.33% -185.88%
Acquisitions
YoY Change
Other Investing Activities -$1.840M $500.0K
YoY Change -81.18%
Cash From Investing Activities -$1.940M $427.0K
YoY Change -80.25% -602.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 42.00K
YoY Change
NET CHANGE
Cash From Operating Activities 370.0K -993.0K
Cash From Investing Activities -1.940M 427.0K
Cash From Financing Activities 0.000 42.00K
Net Change In Cash -1.570M -524.0K
YoY Change -82.74% -68.43%
FREE CASH FLOW
Cash From Operating Activities $370.0K -$993.0K
Capital Expenditures $100.0K $73.00K
Free Cash Flow $270.0K -$1.066M
YoY Change -65.3% -28.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18651000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18557000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
437000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
406000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
397000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
495000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
197000 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
4874000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31361303
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31272303
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30385297
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30296297
CY2022Q4 ftek Contract With Customer Contracts In Progress Number Of Contracts Identified As Loss Contracts
ContractWithCustomerContractsInProgressNumberOfContractsIdentifiedAsLossContracts
0 pure
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
976006
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2251000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
159000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33059
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5657551
dei Entity Address Address Line1
EntityAddressAddressLine1
27601 Bella Vista Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Warrenville
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60555-1617
dei City Area Code
CityAreaCode
630
dei Local Phone Number
LocalPhoneNumber
845-4500
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
FTEK
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30385297
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15134000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23328000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
12855000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2981000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6781000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7729000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
528000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
392000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1287000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1395000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
36585000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
35825000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4368000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4435000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
2116000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2116000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
382000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
6360000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
789000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
794000 usd
CY2023Q2 us-gaap Assets
Assets
49609000 usd
CY2022Q4 us-gaap Assets
Assets
50124000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3097000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2710000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
107000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
615000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1105000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1307000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
826000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5126000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4766000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
376000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
177000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
177000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
280000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
274000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
5959000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5283000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
313000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
313000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164651000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164422000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117449000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115991000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1690000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1728000 usd
CY2023Q2 us-gaap Convertible Debt
ConvertibleDebt
76000 usd
CY2022Q4 us-gaap Convertible Debt
ConvertibleDebt
76000 usd
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2251000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2251000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43650000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
44841000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49609000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50124000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5461000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12748000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11903000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
3465000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
3690000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7947000 usd
us-gaap Cost Of Revenue
CostOfRevenue
6935000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2915000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2874000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6160000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5928000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
413000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
289000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
631000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
509000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
6793000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
6853000 usd
us-gaap Costs And Expenses
CostsAndExpenses
14738000 usd
us-gaap Costs And Expenses
CostsAndExpenses
13372000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1332000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-485000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1990000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1469000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
5000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
4000 usd
us-gaap Interest Expense
InterestExpense
10000 usd
us-gaap Interest Expense
InterestExpense
9000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
307000 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
646000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
9000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
134000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-104000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
124000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1044000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-347000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1458000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1345000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1044000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-356000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1458000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1354000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30324000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30296000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30310000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30282000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30324000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30296000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30310000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30282000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1044000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-356000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1458000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1354000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-48000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-222000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-292000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1092000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-578000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1420000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1646000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
46200000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-998000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-70000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
17000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
45133000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-356000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-222000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
44583000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
44841000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-414000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
86000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
44602000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1044000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-48000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
98000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
42000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43650000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1458000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1354000 usd
us-gaap Depreciation
Depreciation
154000 usd
us-gaap Depreciation
Depreciation
182000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
30000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
50000 usd
us-gaap Interest And Dividend Income Securities Held To Maturity
InterestAndDividendIncomeSecuritiesHeldToMaturity
203000 usd
us-gaap Interest And Dividend Income Securities Held To Maturity
InterestAndDividendIncomeSecuritiesHeldToMaturity
-0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
43000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
187000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
46000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-966000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3245000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
135000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
58000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-114000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-205000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
383000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
812000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-21000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3321000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
103000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
138000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
9685000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
-0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1500000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8288000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-138000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
42000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
-0 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
17000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-280000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8194000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3756000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23328000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37054000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15134000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33298000 usd
CY2023Q2 us-gaap Cash
Cash
12354000 usd
CY2022Q2 us-gaap Cash
Cash
23298000 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2780000 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
8010000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1990000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15134000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33298000 usd
CY2022Q4 ftek Investment Plan Maximum Amount Approved
InvestmentPlanMaximumAmountApproved
20000000 usd
CY2023Q2 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
17729000 usd
CY2022Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
9341000 usd
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0 usd
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
225000 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
168000 usd
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
17504000 usd
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
9173000 usd
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
12855000 usd
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
12751000 usd
CY2023Q2 ftek Debt Securities Heldtomaturity Amortized Cost After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesHeldtomaturityAmortizedCostAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
4408000 usd
CY2023Q2 ftek Debt Securities Heldtomaturity Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesHeldtomaturityFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
4300000 usd
CY2023Q2 ftek Debt Securities Heldtomaturity Amortized Cost After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Two Through Three
DebtSecuritiesHeldtomaturityAmortizedCostAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTwoThroughThree
466000 usd
CY2023Q2 ftek Debt Securities Heldtomaturity Fair Value Maturity Allocated And Single Maturity Date After Year Two Through Three
DebtSecuritiesHeldtomaturityFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwoThroughThree
453000 usd
CY2023Q2 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
17729000 usd
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
17504000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
223000 usd
CY2022 ftek Provision For Doubtful Accounts Including Foreign Impact Of Foreign Exchange
ProvisionForDoubtfulAccountsIncludingForeignImpactOfForeignExchange
-19000 usd
CY2022 ftek Allowance For Doubtful Accounts Receivable Chargeoffs Recoveries
AllowanceForDoubtfulAccountsReceivableChargeoffsRecoveries
94000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
110000 usd
ftek Provision For Doubtful Accounts Including Foreign Impact Of Foreign Exchange
ProvisionForDoubtfulAccountsIncludingForeignImpactOfForeignExchange
0 usd
ftek Allowance For Doubtful Accounts Receivable Chargeoffs Recoveries
AllowanceForDoubtfulAccountsReceivableChargeoffsRecoveries
-0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
110000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5461000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12748000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11903000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5461000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12748000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11903000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5461000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12748000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11903000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
938000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
372000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
390000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
368000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
20000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
250000 usd
CY2023Q2 ftek Contract With Customer Contracts In Progress Number Of Contracts Identified As Loss Contracts
ContractWithCustomerContractsInProgressNumberOfContractsIdentifiedAsLossContracts
0 pure
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6613000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6305000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3804000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4605000 usd
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2946000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3082000 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
141000 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
152000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
110000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
110000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6781000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7729000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
976006
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2251000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30324000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30296000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30310000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30282000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30324000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30296000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30310000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30282000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
384500
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
70000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.85
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
270500
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y21D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
270500
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
289000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-485000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12748000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7947000 usd
us-gaap Gross Profit
GrossProfit
4801000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6160000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y21D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2850000
CY2022Q2 ftek Percentage Of Face Amount Of Letters Of Credit As Collateral
PercentageOfFaceAmountOfLettersOfCreditAsCollateral
1.50 pure
CY2022Q2 ftek Payment Basis Points On Face Value Of Letters Of Credit
PaymentBasisPointsOnFaceValueOfLettersOfCredit
0.0250 pure
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
414000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5461000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
3465000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1996000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2915000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
413000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1332000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6368000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
3690000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2678000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2874000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
631000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1990000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11903000 usd
us-gaap Cost Of Revenue
CostOfRevenue
6935000 usd
us-gaap Gross Profit
GrossProfit
4968000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5928000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
509000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1469000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5461000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12748000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11903000 usd
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
49609000 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
50124000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
938000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
372000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
159000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
159000 usd
CY2023Q2 ftek Other Accrued Liabilities Miscellaneous Current
OtherAccruedLiabilitiesMiscellaneousCurrent
210000 usd
CY2022Q4 ftek Other Accrued Liabilities Miscellaneous Current
OtherAccruedLiabilitiesMiscellaneousCurrent
295000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1307000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
826000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
159000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd

Files In Submission

Name View Source Status
0001437749-23-022534-index-headers.html Edgar Link pending
0001437749-23-022534-index.html Edgar Link pending
0001437749-23-022534.txt Edgar Link pending
0001437749-23-022534-xbrl.zip Edgar Link pending
ex_533393.htm Edgar Link pending
ex_533394.htm Edgar Link pending
ex_533395.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ftek-20230630.xsd Edgar Link pending
ftek20230630_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
ftek-20230630_cal.xml Edgar Link unprocessable
ftek-20230630_def.xml Edgar Link unprocessable
ftek-20230630_lab.xml Edgar Link unprocessable
ftek-20230630_pre.xml Edgar Link unprocessable
ftek20230630_10q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable